Direct comparison of logistic regression and recursive partitioning to predict chemotherapy response of breast cancer based on clinical pathological variables.

Date publication

septembre 2009

Journal

Breast cancer research and treatment

Auteurs

Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles

Tous les auteurs :
Rouzier R, Coutant C, Lesieur B, Mazouni C, Incitti R, Natowicz R, Pusztai L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/19152025

Résumé

The purpose was to compare logistic regression model (LRM) and recursive partitioning (RP) to predict pathologic complete response to preoperative chemotherapy in patients with breast cancer. The two models were built in a same training set of 496 patients and validated in a same validation set of 337 patients. Model performance was quantified with respect to discrimination (evaluated by the areas under the receiver operating characteristics curves (AUC)) and calibration. In the training set, AUC were similar for LRM and RP models (0.77 (95% confidence interval, 0.74-0.80) and 0.75 (95% CI, 0.74-0.79), respectively) while LRM outperformed RP in the validation set (0.78 (95% CI, 0.74-0.82) versus 0.64 (95% CI, 0.60-0.67). LRM model also outperformed RP model in term of calibration. In these real datasets, LRM model outperformed RP model. It is therefore more suitable for clinical use.

Mots clés

Antineoplastic Agents, therapeutic use, Area Under Curve, Breast Neoplasms, drug therapy, Chemotherapy, Adjuvant, Female, Humans, Logistic Models, Middle Aged, Models, Statistical, Neoplasm Staging, ROC Curve, Treatment Outcome

Référence

Breast Cancer Res. Treat.. 2009 Sep;117(2):325-31